News & Events - SafeMinds News & Events - SafeMinds

News & Events

September 29, 2020

Tragic Autism Wandering Case Triggers Change at the FBI

A North Carolina community was left reeling when the body of a six-year-old boy with autism was discovered in a local park partially submerged in a creek. It was just two years ago when Maddox Ritch wandered off from his family at Gastonia Park. He was found lifeless five days later. Maddox’s death was ruled an accidental drowning.

September 29, 2020

New Study Reveals COVID-19 Restrictions Greatly Affected Individuals with Developmental Disabilities

Researchers from UCLA, Rutgers University and the National Institute of Mental Health recently released a study showing that individuals with developmental disabilities have experienced critical losses of educational and medical therapies since the coronavirus stay-at-home orders began last March.

September 29, 2020

How to Identify and Understand Autism Research

Sifting through scientific and medical autism spectrum disorder studies can be very overwhelming. The Autism Research Institute (ARI) understands this feeling and has recently published a helpful guide for caregivers to interpret and assess research.

September 28, 2020

Federal Civil Rights Commission Urges End to Subminimum Wage

Since 1938, a provision in Section 14 (c) of the Fair Labor Standards permitted employers to obtain certificates from the Department of Labor which allowed paying individuals with disabilities less than the federal minimum wage. Cities and states across the nation that are uncomfortable with this provision have imposed restrictions to stop this practice.

September 28, 2020

At Home Sensory Activities as Remote Learning Continues

A parent support group for children with sensory processing difficulties has published a helpful list of 100 activities that can be incorporated into a home remote learning environment. The group recommends that children with sensory issues take a two to three-minute movement break every ten to fifteen minutes.

microbiome illustration on glass
September 23, 2020

Finch Therapeutics Raises $90 Million for Microbiome Medication

Finch Therapeutics Group has raised $90 million to push its oral microbiome drug to treat recurrent C. difficile infection toward a regulatory submission with the FDA. The money raised will also be used to initiate a Phase 1b study evaluating a similar drug for autism spectrum disorder, as well as to advance treatments for chronic hepatitis B infection, ulcerative colitis and Crohn’s disease.

Hide Buttons